Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2025-12-24 @ 7:04 PM
NCT ID:
NCT00840957
Eligibility Criteria:
Inclusion Criteria:
* Rheumatoid arthritis according to ACR criteria
* Patient already receiving infliximab for more than 14 weeks
* No modification of the dose regimen of infliximab since the last infusion
* No modification of disease modifying anti rheumatic drugs since the last 4 weeks
Exclusion Criteria:
* Surgery scheduled during the duration of the study
* Pregnancy
* infection, malignancy, immune reaction to infliximab or demyelinating diseases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00840957
Study Brief:
Protocol Section:
NCT00840957